Which has grown faster, SPRY or SRTA?

Over the past five years, SRTA grew revenue faster — SPRY at a 36.43% CAGR versus SRTA at 46.05%.

Is SPRY or SRTA more profitable?

SRTA runs the higher net margin — SPRY at -184.24% versus SRTA at 15.71%.

How have SPRY and SRTA total returns compared?

Over the past 5 years, SPRY delivered -16.35% and SRTA delivered -13.77% annualized total return. Past performance doesn't predict future results.

ARS Pharmaceuticals, Inc. (SPRY) vs Strata Critical Medical, Inc. (SRTA)

A side-by-side comparison of ARS Pharmaceuticals, Inc. and Strata Critical Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SPRY

ARS Pharmaceuticals, Inc.

$425M

$4.28HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT

SRTA

Strata Critical Medical, Inc.

$412M

$4.76HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT

Total return — SPRY vs SRTA

growth of $100 · dividends reinvested · last 6y

SPRY -82.8% (-25.5%/yr)SRTA -52.6% (-11.7%/yr)SRTA compounded faster over this window

SPRY SRTA

SPRY vs SRTA: by the numbers

•SPRY is the larger company ($425M vs $412M market cap).
•SRTA is profitable (15.71% net margin) while SPRY runs a net loss (-184.24%).
•SRTA grew revenue faster over the past five years (46.05% vs 36.43% CAGR).

Metrics side by side

Valuation

Metric	SPRY	SRTA
P/E ratio	N/A	9.57
P/S ratio	3.64	1.61
P/B ratio	33.98	1.48

Profitability

Metric	SPRY	SRTA
Gross margin	73.89%	20.56%
Operating margin	-212.92%	-7.97%
Net margin	-184.24%	15.71%
ROE	-1721.80%	14.40%
ROIC	-114.65%	-7.11%

Growth (annualized)

Metric	SPRY	SRTA
Revenue CAGR (5Y)	36.43%	46.05%
Total return CAGR (5Y)	-16.35%	-13.77%

Frequently asked

Which has grown faster, SPRY or SRTA?: Over the past five years, SRTA grew revenue faster — SPRY at a 36.43% CAGR versus SRTA at 46.05%.
Is SPRY or SRTA more profitable?: SRTA runs the higher net margin — SPRY at -184.24% versus SRTA at 15.71%.
How have SPRY and SRTA total returns compared?: Over the past 5 years, SPRY delivered -16.35% and SRTA delivered -13.77% annualized total return. Past performance doesn't predict future results.

Go deeper

Full SPRY analysis Full SRTA analysis Interactive comparison tool

Dig into the metrics

Strata Critical Medical P/E ratio ARS Pharmaceuticals ROE Strata Critical Medical ROE ARS Pharmaceuticals operating margin Strata Critical Medical operating margin ARS Pharmaceuticals revenue growth Strata Critical Medical revenue growth ARS Pharmaceuticals free cash flow Strata Critical Medical free cash flow

ARS Pharmaceuticals & Strata Critical Medical appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.